Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.
Oncoinvent has raised $11.8M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2024.
Oncoinvent's investors include Hadean Ventures, Canica, MP Pensjon, Watrium AS, Geveran Trading.
Oncoinvent is headquartered in Oslo, Norway.
Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.
Oncoinvent is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncoinvent — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/oncoinvent. Accessed November 17, 2026.
VCBacked. (2024). Oncoinvent — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/oncoinvent
{{cite web |title=Oncoinvent — Funding & Investors |url=https://www.vcbacked.co/company/oncoinvent |website=VCBacked |access-date=November 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Oncoinvent? Request a listing update